Skip to main content
OpenTrials

Clinical trial condition

MDS

Explore clinical trials studying MDS. Study availability and eligibility vary by location and protocol.

105 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

MDS trial results

Completed

DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2

NCT03466320

Conditions
AML, MDS
Locations
  • University of Colorado Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • New York School of Medicine New York, United States
View Trial Details
Completed

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

NCT01241500

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 87 locations
View Trial Details
Completed

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

NCT00462761

Conditions
AML, Acute Myeloid Leukemia, Aortic aneurysm, familial thoracic 4, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia
View Trial Details
Completed

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

NCT00652626

Conditions
AML, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations
  • Sutter East Bay Hospitals Berkeley, California, United States
  • Palm Springs Research Institute Hialeah, Florida, United States
  • MCG Cancer Center Augusta, Georgia, United States
  • Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View Trial Details

Related conditions